NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
RXRX Technical Analysis
5
As on 24th Dec 2024 RXRX STOCK Price closed @ 7.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.30 & Strong Sell for SHORT-TERM with Stoploss of 10.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RXRXSTOCK Price
Open | 7.24 | Change | Price | % |
High | 7.34 | 1 Day | 0.25 | 3.58 |
Low | 6.94 | 1 Week | 0.29 | 4.17 |
Close | 7.24 | 1 Month | -0.60 | -7.65 |
Volume | 13658058 | 1 Year | -5.20 | -41.80 |
52 Week High 15.86 | 52 Week Low 5.09 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
LMDX | 0.02 | 0.00% |
LCID | 3.20 | 3.23% |
AVGR | 1.45 | 126.56% |
NVDA | 140.22 | 0.39% |
AKTS | 0.04 | 0.00% |
TNXP | 0.39 | -2.50% |
PONO | 1.72 | 2.38% |
TELL | 1.00 | 0.00% |
TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
RXRX Daily Charts |
RXRX Intraday Charts |
Whats New @ Bazaartrend |
RXRX Free Analysis |
|
RXRX Important Levels Intraday
RESISTANCE | 8.01 |
RESISTANCE | 7.76 |
RESISTANCE | 7.61 |
RESISTANCE | 7.46 |
SUPPORT | 7.02 |
SUPPORT | 6.87 |
SUPPORT | 6.72 |
SUPPORT | 6.47 |
RXRX Forecast December 2024
4th UP Forecast | 11.77 |
3rd UP Forecast | 10.32 |
2nd UP Forecast | 9.42 |
1st UP Forecast | 8.52 |
1st DOWN Forecast | 5.96 |
2nd DOWN Forecast | 5.06 |
3rd DOWN Forecast | 4.16 |
4th DOWN Forecast | 2.71 |
RXRX Weekly Forecast
4th UP Forecast | 14.68 |
3rd UP Forecast | 12.29 |
2nd UP Forecast | 10.82 |
1st UP Forecast | 9.34 |
1st DOWN Forecast | 5.14 |
2nd DOWN Forecast | 3.66 |
3rd DOWN Forecast | 2.19 |
4th DOWN Forecast | -0.20 |
RXRX Forecast2024
4th UP Forecast | 29.94 |
3rd UP Forecast | 22.66 |
2nd UP Forecast | 18.16 |
1st UP Forecast | 13.66 |
1st DOWN Forecast | 0.82 |
2nd DOWN Forecast | -3.68 |
3rd DOWN Forecast | -8.18 |
4th DOWN Forecast | -15.46 |
Recursion Pharmaceuticals Inc ( NASDAQ USA Symbol : RXRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RXRX Other Details
Segment | EQ | |
Market Capital | 3231504128.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
RXRX Address
RXRX Latest News
RXRX Business Profile
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah. Address: 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service